Spectrum Pharma (SPPI) – Trading Halts
-
Spectrum Pharma (SPPI) says FDA committee voted 9-4 that current benefits of poziotinib did not outweigh its risks
-
Spectrum Pharma (SPPI) halted, news pending
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SPPI Stock Lookup